Ministry of Ayush has launched a collaborative study titled “Clinical Study on Ayurveda as an Adjunct Therapy for Tuberculosis” in partnership with the Department of Biotechnology (DBT).
The joint announcement was made by Dr Jitendra Singh, Minister of State (Independent Charge), Ministry of Science and Technology and Prataprao Jadhav, Minister of State (Independent Charge) of the Ministry of Ayush and Minister of State in the Ministry of Health & Family Welfare in the presence of senior officials and scientists of the Ministries.
Prof. Vaidya Rabinarayan Acharya, Director General of the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Government of India and BRIC- Director of the National Institute of Immunology (NII), Dr Debasisa Mohanty presented a brief overview of the collaborative clinical study.
The presentation detailed the scientific design, objectives, and expected outcomes of the study, which aims to evaluate the efficacy, safety, and tolerability of an Ayurveda regimen as an adjunct to standard anti-tuberculosis treatment (ATT), along with macronutrient supplementation.
To be conducted across premier institutions including AIIMS, JIPMER, and NEIGRIHMS, the 24-month study aims to generate robust scientific evidence on improving nutritional outcomes, accelerating recovery, and enhancing quality of life among TB patients, further strengthening India’s commitment to innovative, patient-centric approaches for TB elimination.
A key highlight of the event was the exchange of a Memorandum of Understanding (MoU) between BRIC-Translational Health Science and Technology Institute (THSTI) and CCRAS, formalising institutional collaboration.
